Login / Signup

Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation.

Zhao YinJing SunYing YangNa XuLing JiangZhiping FanFen HuangPengcheng ShiZhixiang WangLi XuanJun XuQifa LiuGuopan Yu
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
Our study suggests that CDV is potentially an option for the salvage treatment of CMV infection in the haplo-HSCT patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • acute myeloid leukemia
  • bone marrow
  • peripheral blood
  • patient reported outcomes
  • high dose
  • decision making